674 results on '"McAlpine, Jessica N."'
Search Results
52. QPOLE: A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
53. Improving response to progestin treatment of low-grade endometrial cancer
54. FIGO 2023 endometrial cancer staging: too much, too soon?
55. Mismatch repair deficiency and prognostic significance in patients with low-risk endometrioid endometrial cancers
56. Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma
57. Abstract 223: Identifying gene amplifications in p53 abnormal endometrial carcinomas by shallow whole genome sequencing
58. Abstract 4542: Development of a one-step molecular classifier for endometrial carcinoma using an amplicon-based gene panel and next generation sequencing technology
59. Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death
60. Data from Tumor Growth Inhibition by Olaparib in BRCA2 Germline-Mutated Patient-Derived Ovarian Cancer Tissue Xenografts
61. Supplementary Data from FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes
62. Figure S3 from Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type
63. Supplementary Methods from Population Distribution of Lifetime Risk of Ovarian Cancer in the United States
64. Supplementary Data from Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma
65. Supplementary Figures from Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma
66. Data from Population Distribution of Lifetime Risk of Ovarian Cancer in the United States
67. Supplementary Tables from Molecular Subtype Not Immune Response Drives Outcomes in Endometrial Carcinoma
68. Supplementary Figure S1 from Tumor Growth Inhibition by Olaparib in BRCA2 Germline-Mutated Patient-Derived Ovarian Cancer Tissue Xenografts
69. Multipath contrast of optical coherence tomography for early cancer detection (Conference Presentation)
70. Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice
71. p53-Abnormal “Fields of Dysplasia” in Human Papillomavirus–Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk
72. QPOLE:A Quick, Simple, and Cheap Alternative for POLE Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction
73. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
74. Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
75. Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment
76. Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study
77. Treatment related outcomes in high-risk endometrial carcinoma: Canadian high risk endometrial cancer consortium (CHREC)
78. Canadian high risk endometrial cancer (CHREC) consortium: Analyzing the clinical behavior of high risk endometrial cancers
79. Causes of death among women with epithelial ovarian cancer by length of survival post-diagnosis: a population-based study in British Columbia, Canada
80. The molecular origin and taxonomy of mucinous ovarian carcinoma
81. The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype
82. Clinical and pathological characterization of endometrial cancer in young women: Identification of a cohort without classical risk factors
83. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
84. Data Set for the Reporting of Carcinomas of the Vulva: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
85. Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma
86. Determinants of Quality of Life in Ovarian Cancer Survivors: A Pilot Study
87. The Fallopian Tube as the Origin of High Grade Serous Ovarian Cancer: Review of a Paradigm Shift
88. Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
89. Endometrial Cancer Presentation and Outcomes Based on Mismatch Repair Protein Expression From a Population-Based Study
90. Changing Clinical Practice: Evaluation of Implementing Recommendations for Opportunistic Salpingectomy in British Columbia and Ontario
91. Risk-reducing Surgery in Women at Low Lifetime Risk of Developing Ovarian Carcinoma: Opportunistic Salpingectomy
92. Foreword
93. Survival Benefit of Adjuvant Radiotherapy: An Analysis of Low-Stage Invasive Ovarian Mucinous Carcinomas
94. HPV-independent Differentiated Vulvar Intraepithelial Neoplasia (dVIN) is Associated With an Aggressive Clinical Course
95. Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.
96. Long-term mortality among women with epithelial ovarian cancer: a population-based study in British Columbia, Canada
97. Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers
98. A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention
99. Spatial expression of theFGFR2bsplice isoform and its prognostic significance in endometrioid endometrial carcinoma
100. Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.